FDA Adverse Event Injury Summary report: N

PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT

MDR report key: 10782108 · Received November 3, 2020

Report

Report Number
2210968-2020-08630
Event Type
Injury
Date Received
November 3, 2020
Date of Event
January 2, 2019
Report Date
October 12, 2020
Manufacturer
ETHICON INC.
Product Code
GAW
PMA / PMN Number
K133356
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT: (B)(4). (B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. ATTEMPTS ARE BEING MADE TO OBTAIN THE ADDITIONAL INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT THE LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE AUTHOR/SURGEON BELIEVE THAT ETHICON PRODUCTS (PROLENE SUTURE) INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? DOES THE AUTHOR/SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH THE ETHICON PRODUCTS (PROLENE SUTURE) USED IN THIS PROCEDURE? WERE THESE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PLEASE PROVIDE PATIENT DEMOGRAPHICS: FOR THE PATIENTS IN TABLE 1, FOR PATIENTS 1 THROUGH IX, PLEASE PROVIDE THE PATIENT DEMOGRAPHICS FROM TABLE 4 THAT ALIGN WITH THE PATIENTS IN TABLE 1. FOR THE PATIENTS IN TABLE 2, FOR PATIENTS 1 THROUGH VIII, PLEASE PROVIDE THE PATIENT DEMOGRAPHICS FROM TABLE 4 THAT ALIGN WITH THE PATIENTS IN TABLE 2. CITATION: TECHNIQUES IN COLOPROCTOLOGY (2019) 23:43¿52. DOI: HTTPS://DOI.ORG/10.1007/S10151-018-1918-7 EVENTS WERE SUBMITTED VIA 2210968-2020-08621 FOR UNIDENTIFIED PATIENTS, AND PATIENTS WITH RECURRENCE: 2210968-2020-08622, 2210968-2020-08623, 2210968-2020-08624, 2210968-2020-08626, 2210968-2020-08627, 2210968-2020-08628, 2210968-2020-08629, AND 2210968-2020-08631.

Description of Event or Problem · 1

TITLE: GRACILIS MUSCLE TRANSPOSITION FOR TREATMENT OF RECURRENT ANOVAGINAL, RECTOVAGINAL, RECTOURETHRAL, AND POUCH¿VAGINAL FISTULAS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTIVENESS OF GRACILIS MUSCLE TRANSPOSITION (GMT) TO TREAT RECURRENT ANOVAGINAL, RECTOVAGINAL, RECTOURETHRAL, AND POUCH¿VAGINAL FISTULAS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD). THIS RETROSPECTIVE STUDY INVOLVES 32 PATIENTS (2 MALE AND 30 FEMALE; MEAN AGE: 39 YEARS; AGE RANGE: 24¿55 YEARS) WITH IBD WHO UNDERWENT GRACILIS TRANSPOSITION OR RE-TRANSPOSITION FOR A RECURRENT FISTULA BETWEEN JANUARY 2000 AND MARCH 2018 AND ATTENDED AT LEAST THE FIRST FOLLOW-UP VISIT AT 3 MONTHS. DURING THE PROCEDURE, THE DISTAL TENDON OF THE MUSCLE WAS FIXED WITH PROLENE SUTURES (ETHICON, BRIDGEWATER, NJ AND CINCINNATI, OH, USA) TO THE CONTRALATERAL PUBIC OR ISCHIAL PERIOSTEUM AFTER TRANSPOSITION THROUGH AN ADDITIONAL SUBCUTANEOUS TUNNEL AND A SMALL INCISION ON THIS SIDE. IF THE MEDICAL HISTORY OF THE PATIENT INDICATED FECAL INCONTINENCE, THE DISTAL MUSCLE TENDON WAS TRANSPOSED FURTHER TO ENCIRCLE THE ANAL CANAL, AND FIXED AT THE IPSILATERAL PUBIC OR ISCHIAL PERIOSTEUM, THUS CREATING A LOOP (GAMMA-LOOP) ADDITIONAL PROCEDURES AFTER GMT FOR PATIENTS WITH RECURRENCE: PATIENT VIII WHO UNDERWENT GMT ON 05/2016 HAD RECURRENCE AND UNDERWENT 2 ABSCESS EXCISIONS, FISTULECTOMY, RECTAL FLAP AND STOMA CLOSURE. AT LAST FOLLOW UP, FISTULA WAS CLOSED. THE RESULTS ARE PROMISING AND SUGGEST THAT GMT IS A SAFE AND VERY EFFECTIVE OPTION FOR THE TREATMENT OF RECURRENT FISTULAS IN IBD PATIENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1241762 PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT SUTURE, NONABSORBABLE, SYNTHETIC, POLYPROPYLENE GAW ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention